Terns Pharmaceuticals, Inc., a biopharmaceutical company with a market capitalization of $397 million, disclosed the departure of their Chief Financial Officer (CFO), Mark Vignola, Ph.D., effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback